Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 4.41 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 7.07 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 4.49 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 4.52 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 4.09 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 4.24 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 4.11 | pmol/sample |
| LMST01020011 | CE(20:1) | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 1.29 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 0.0 | BCD100322A01 | 4.17 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 0.5 | BCD100322A03 | 3.54 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 1.0 | BCD100322A07 | 3.13 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 2.0 | BCD100322A11 | 3.07 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 4.0 | BCD100322A15 | 2.12 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 8.0 | BCD100322A19 | 3.07 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 12.0 | BCD100322A23 | 2.18 | pmol/sample |
| LMST01020011 | CE(20:1) | C | 24.0 | BCD100322A27 | 3.08 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 4.71 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 4.92 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 5.2 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 10.6 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 16.8 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 11.4 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 13.8 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 0.5 | BCD100322A04 | 3.7 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 1.0 | BCD100322A08 | 3.62 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 2.0 | BCD100322A12 | 4.33 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 4.0 | BCD100322A16 | 7.51 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 8.0 | BCD100322A20 | 8.68 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 12.0 | BCD100322A24 | 7.73 | pmol/sample |
| LMST01020011 | CE(20:1) | 25OH-Chol | 24.0 | BCD100322A28 | 8.58 | pmol/sample |